Mosanna
2 known investors
Mosanna develops a nighttime nasal spray pharmaceutical treatment for obstructive sleep apnea that reactivates upper airway muscles to restore the body's natural airway control. The product targets sleep apnea patients seeking an alternative to mechanical devices.
HealthtechMedical Devices